Fed up with decisions
News of the day, Friday, February 11
AstraZeneca is announced to become a component of NASDAQ-100 index replacing the Xilinx company there. AstraZeneca has reported 2021 results recently, showing a 41% income growth last compared to 2020. The income rise excluding the Covid-19 vaccine is 26%. In 2021, the company …